RGNX
Regenxbio Inc
7.60$
+1.9%
vs. previous close
Closing price · As of: Oct 7, 2026
Statements
Cash Flow
All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 | LTM* |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| – | – | – | – | – | – | – | -246.7% | – | – | – | – | – | |
| – | -0.8% | -3.6% | -3.1% | -2.2% | +1.6% | -1.7% | -1.3% | -0.5% | -0.4% | -0.3% | -2.6% | – | |
| – | -18.4% | +15.2% | -1.7% | +4.8% | -3.5% | -10.5% | +1.4% | +4.0% | -6.9% | +2.9% | +5.1% | – | |
| – | – | -188.4% | – | – | +92.1% | +40.8% | -54.1% | -237.6% | – | – | – | – | |
| – | -21.8% | -50.5% | -14.9% | -31.2% | +231.0% | -5.1% | -61.8% | +25.6% | +3.5% | +143.1% | -38.5% | – | |
| – | -12.1% | -61.2% | -102.0% | – | -19.9% | +11.1% | -413.9% | – | -11.2% | +88.0% | -6.6% | – | |
| – | – | – | – | – | – | – | – | – | – | – | – | – | |
| – | – | – | – | – | – | – | – | – | -100.0% | – | – | – | |
| – | +148.9% | – | -107.8% | +14.9% | -28.7% | -25.1% | – | -105.1% | +35.3% | +42.3% | – | – | |
| – | – | – | -170.4% | – | – | +7,884.4% | -169.6% | – | – | – | – | – | |
| – | – | – | – | – | – | – | -252.5% | – | – | – | – | – |
LTM = last twelve months (sum of the four most recent quarters).
Data as of: October 7, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.